Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateArizonaVetoed
SB 1212: health insurance; reimbursement rates; vaccines
Janae Shamp
SB 1212 status: Vetoed — Vetoed by Governor (updated Jun 19, 2026).
Source
LegiScan
Confidence
High
Analysis basis
LegiScan full bill text
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
Not enough information
Score:Not enough information
Risk:Moderate Risk
Impact:Moderate Impact 40/100
Constitutionality70%
Bipartisan20%
Public opinion50%
Bill summary
What changes
The legislation mandates that, effective January 1, 2027, health insurers in Arizona cannot adjust reimbursement rates for healthcare providers based on whether a patient has refused to be vaccinated.
Who is affected
Health insurance companies, healthcare providers, and patients who choose not to receive certain vaccines.
Requirements and enforcement
Insurers must standardize their reimbursement policies, ensuring no differential pay based on the vaccination status of the covered individual.
Costs and funding
Administrative costs associated with compliance and re-contracting between insurers and medical providers; potentially higher premiums to cover lost insurer flexibility.
When it takes effect
The bill was intended to take effect on January 1, 2027, but was vetoed.
Potential benefits
Supports patient-provider autonomy and prevents financial discrimination against patients with different vaccination choices.
Risks and tradeoffs
Disruption to established value-based health incentives, administrative burden on insurers, and potential loss of public health improvement tools.
What is still unknown
The exact impact on future value-based care agreements and whether insurers will pass compliance costs onto consumers through premiums.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
45%
Benefits
- Provides predictable reimbursement rates for health professionals.
- Prevents insurance-driven pressure on clinical decision-making.
- Eliminates potential revenue fluctuations based on patient choices.
Risks
- Increases administrative complexity and overhead for insurers.
- Potentially leads to higher insurance premiums to offset insurer risks.
- Interferes with private contractual freedom between insurers and providers.
Society
Mixed / Neutral
55%
Benefits
- Ensures patients can access care without judgment of vaccine status.
- Supports patient autonomy in personal medical decision-making.
- Reduces perceived financial bias against patients choosing non-vaccination.
Risks
- May disrupt clinical initiatives focused on preventive care education.
- Could strain long-term doctor-insurer care coordination models.
- Signals a shift toward limiting insurance-driven public health incentives.
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Not enough information
Not enough information to score this sector.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Public Health & Safety
Mixed / Neutral
40%
Benefits
- Maintains access to care for individuals who refuse specific vaccines.
- Minimizes financial conflict of interest in the clinical space.
- Reduces insurer-led mandates that could impact access to care.
Risks
- Disrupts incentive structures designed to improve public health vaccination rates.
- Limits the capacity for insurers to use payment to drive health compliance.
- Complicates tracking and promotion of preventive health safety metrics.
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
LegiScan
Official bill text or data from LegiScan.
Confidence
High
Information is complete and verified.
Analysis basis
LegiScan full bill text
Source used for this bill's analysis.
Source note
The prohibition on differential reimbursement may conflict with existing value-based care agreements.
Analysis scope
The bill amends only title 20 and does not detail specific enforcement mechanisms.
04
Where it stands
Official recordVetoed by Governor
- IntroducedComplete
- CommitteeComplete
- Chamber votesComplete
- Final agreementComplete
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.